Stock Analysis

iRay Technology's (SHSE:688301) Weak Earnings May Only Reveal A Part Of The Whole Picture

A lackluster earnings announcement from iRay Technology Company Limited (SHSE:688301) last week didn't sink the stock price. However, we believe that investors should be aware of some underlying factors which may be of concern.

Check out our latest analysis for iRay Technology

earnings-and-revenue-history
SHSE:688301 Earnings and Revenue History April 26th 2024
Advertisement

A Closer Look At iRay Technology's Earnings

Many investors haven't heard of the accrual ratio from cashflow, but it is actually a useful measure of how well a company's profit is backed up by free cash flow (FCF) during a given period. The accrual ratio subtracts the FCF from the profit for a given period, and divides the result by the average operating assets of the company over that time. You could think of the accrual ratio from cashflow as the 'non-FCF profit ratio'.

Therefore, it's actually considered a good thing when a company has a negative accrual ratio, but a bad thing if its accrual ratio is positive. While it's not a problem to have a positive accrual ratio, indicating a certain level of non-cash profits, a high accrual ratio is arguably a bad thing, because it indicates paper profits are not matched by cash flow. That's because some academic studies have suggested that high accruals ratios tend to lead to lower profit or less profit growth.

Over the twelve months to December 2023, iRay Technology recorded an accrual ratio of 0.73. Statistically speaking, that's a real negative for future earnings. To wit, the company did not generate one whit of free cashflow in that time. Even though it reported a profit of CN¥607.5m, a look at free cash flow indicates it actually burnt through CN¥1.5b in the last year. Coming off the back of negative free cash flow last year, we imagine some shareholders might wonder if its cash burn of CN¥1.5b, this year, indicates high risk.

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

Our Take On iRay Technology's Profit Performance

As we discussed above, we think iRay Technology's earnings were not supported by free cash flow, which might concern some investors. As a result, we think it may well be the case that iRay Technology's underlying earnings power is lower than its statutory profit. But the good news is that its EPS growth over the last three years has been very impressive. At the end of the day, it's essential to consider more than just the factors above, if you want to understand the company properly. In light of this, if you'd like to do more analysis on the company, it's vital to be informed of the risks involved. To help with this, we've discovered 2 warning signs (1 makes us a bit uncomfortable!) that you ought to be aware of before buying any shares in iRay Technology.

This note has only looked at a single factor that sheds light on the nature of iRay Technology's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying to be useful.

Valuation is complex, but we're here to simplify it.

Discover if iRay Group might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About SHSE:688301

iRay Group

Researches, develops, produces, sells, and services x-ray system components for use in medical, dental, oncology, veterinary, security, and nondestructive testing applications in China and internationally.

Excellent balance sheet with reasonable growth potential.

Advertisement

Weekly Picks

WE
WealthAP
PYPL logo
WealthAP on PayPal Holdings ·

The "Sleeping Giant" Stumbles, Then Wakes Up

Fair Value:US$8229.7% undervalued
47 users have followed this narrative
4 users have commented on this narrative
28 users have liked this narrative
WO
BMBL logo
woodworthfund on Bumble ·

Swiped Left by Wall Street: The BMBL Rebound Trade

Fair Value:US$961.3% undervalued
15 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
WE
WealthAP
DUOL logo
WealthAP on Duolingo ·

Duolingo (DUOL): Why A 20% Drop Might Be The Entry Point We've Been Waiting For

Fair Value:US$268.6434.2% undervalued
32 users have followed this narrative
5 users have commented on this narrative
8 users have liked this narrative

Updated Narratives

YI
GOOGL logo
yiannisz on Alphabet ·

The Real Power Behind Alphabet’s Growth

Fair Value:US$192.5470.7% overvalued
22 users have followed this narrative
1 users have commented on this narrative
0 users have liked this narrative
YI
RELX logo
yiannisz on RELX ·

RELX: The Quiet Compounder Powering Law, Science, and Risk Intelligence

Fair Value:US$41.224.7% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
YI
CVS logo
yiannisz on CVS Health ·

Why CVS’s Valuation Signals Opportunity

Fair Value:US$104.0122.8% undervalued
102 users have followed this narrative
9 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

AG
Agricola
EXN logo
Agricola on Excellon Resources ·

A case for CA$31.80 (undiluted), aka 8,616% upside from CA$0.37 (an 86 bagger!).

Fair Value:CA$31.898.3% undervalued
70 users have followed this narrative
13 users have commented on this narrative
23 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$253.0227.0% undervalued
1029 users have followed this narrative
6 users have commented on this narrative
29 users have liked this narrative
AL
RKLB logo
AlexLovell on Rocket Lab ·

Early mover in a fast growing industry. Likely to experience share price volatility as they scale

Fair Value:US$16.25422.1% overvalued
73 users have followed this narrative
1 users have commented on this narrative
18 users have liked this narrative